Download biomedica product list
2025 opportunities: FGF23 ELISA kits available for the US
Biomedica’s FGF23 ELISA kits now available for the US Biotech community at 25% trial discount.
FGF23 is an endocrine hormone regulating phosphate homeostasis by modulating renal phosphate reabsorption, vitamin D metabolism and parathyroid hormone (PTH) secretion. Epidemiological data suggest that higher FGF23 concentrations are associated with all-cause mortality, cardiovascular mortality, a higher risk of myocardial infarction, stroke and heart failure.
➡️ Learn more: FGF23 – An Overview
Biomedica’s FGF23 (intact) and FGF23 (C-terminal) ELISA kits
Biomedica’s FGF23 ELISA kits, widely recognized in Europe and Asia, are now also available in the US.
💡 What makes them a game-changer?
✓ MULTI-MATRIX: for plasma, serum, cell-culture
✓ CONVENIENT: 50 µl sample/well, all buffers included
✓ RELIABLE: validated following quality guidelines
✓ COMPARABLE: good correlation with existing kits
✓ EASY HANDLING: 7 prediluted standards, 2 controls
✓ TRUSTED: cited in more than 80 publications
Biomedica offers world-leading quality products at competitive pricing.
🚨 Don’t miss out and order your trial kit at 25% discount. Promotion valid until April 15, 2025.
➡️ Contact our US partners for your study quote.
Related kits: Sclerostin . OPG . Periostin . Vanin-1 . NT-proBNP . NT-proANP